Elyse Klerman

Elyse Klerman practices at University Hospitals Parma Medical Center in Parma, Ohio, part of University Hospitals Health System.

Elyse Klerman's NPI, 1396132221, was assigned on April 17, 2015. Elyse Klerman holds New York license 294679-1.

Elyse Klerman's primary practice is University Hospitals Parma Medical Center, at 7007 Powers Boulevard, Parma, OH 44129 in Cuyahoga County. The practice phone is (440) 743-3000.

Elyse Klerman's primary practice is University Hospitals Parma Medical Center in Parma, Ohio, part of University Hospitals Health System. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Elyse Klerman to 5 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elyse Klerman practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Elyse Klerman's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Elyse Klerman is licensed in New York.

CMS data shows 593 Medicare services from Elyse Klerman across 5 procedure codes in 2024, for 474 Medicare patients. Medicare paid $63,464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 474 Medicare patients who saw Elyse Klerman in 2024. The largest group is 75 to 84, with 166 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Elyse Klerman's median patient age at 74, with 55% women.

In 2024, Elyse Klerman wrote 84 Medicare Part D claims for 66 patients. 93% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $85 in total drug cost. In 2019, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Elyse Klerman for performance year 2024, reported through an alternative payment model (APM).

CMS Open Payments shows 1 general payment to Elyse Klerman from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $12.